- Size, Trend, Share, Opportunity Analysis & Forecast, 2014-2025
Global Multiplex Assays Market is expected to grow at a CAGR of 7.8% from 2017 to 2025. Multiplex assays analyze multiple analytes, simultaneously. These are used in functional genomics to detect the different types of biomolecules such as DNA, and proteins of the same class at the same time. Hence, using multiplex assays save time and manual efforts as compared to conventional assays.
Multiplex Assays Market is segmented on the basis of type, products & services, technology, application, and geography. Based on type the multiplex assays market is bifurcated as nucleic acid-based and protein-based multiplex assays. The market is bifurcated as multiplex assays consumables, multiplex assays software and services, and multiplex assay instruments and accessories. Based on technology, it is classified into companion diagnostics, R&D, diseases, and other applications. By Geography, it is categorized into North America, Europe, Asia-Pacific, and LAMEA.
Multiplex Assays Market Dynamics:
Increase in R&D in the pharmaceutical and biotechnology companies for the treatment of diseases such as cancer and Alzheimers.
Multiplex assays increase the efficiency of experiments and therapies.
Decrease in operational cost and manual labor.
High capital investment.
Multiplex Assays Market Players:
The top players in the global multiplex assays market include Luminex Corporation, Illumina, Inc., Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Meso Scale Diagnostics, LLC, QIAGEN N.V., Becton, Dickinson and Company, Abcam PLC, Seegene Inc., and Randox Laboratories Ltd. Market players for global multiplex assays market adopt different strategies such as product development, product approval, acquisition, and collaboration to keep pace with the evolving market trends.
By Products & Services
Please Select Format
Need More Information
Why Progressive Markets
The market research services provided by Progressive Markets are restricted to publications, which may also include insignificant market data. The services are for the internal use of customers only and they do not have any rights to utilize this data for general publications or/and disclosure to third parties. As data is gathered through research activities such as online surveys and interviews with industry experts, it may have variations and fluctuation due to constantly changing market conditions. Thus, Progressive Markets holds no responsibility for misleading or false information gathered from these sources.
Progressive Markets understands and respects the privacy of persona
Recently Viewed Reports
In vitro fertilization (IVF) is an artificial fertilization process that is performed in the laboratory under artificial environment. The colloquial term for babies conceived through the IVF procedures is test-tube ... Read More >>